Figure 1From: SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinomaKaplan-Meier survival analysis of SSX2IP expression level in 51 HCC patients. The survival time in SSX2IP high expression group (n = 31) was shorter than in the low expression group (n = 20), the difference was significant (P = 0.004).Back to article page